drugset / Trial / NCT04185350
Clinical Evaluation of 68Ga-NOTA-MAL-Cys39-exendin-4 Positron Emission Tomography in the Detection of Insulinoma
NaSingle-groupOpen-labelDiagnostic
Summary
Glucagon-like peptide-1 receptor (GLP-1R) is a kind of G protein coupled receptor which regulate the insulin secretion and serves as potential target in the diagnosis of functional pancreas neuroendocrine tumor. The aim of this study was the clinical evaluation of a potential GLP-1R targeted tracer 68Ga-NOTA-MAL-Cys39-exendin-4 for the detection of insulinoma.
Timeline
- Start
- 2019-05-05
- Primary completion
- 2020-04-05
- Completion
- 2020-05-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 68Ga-NOTA-MAL-Cys39-exendin-4 | Diagnostic / imaging agent | 111 mbq | Intravenous |
| Subject | 68Ga-NOTA-MAL-Cys39-exendin-4 | Diagnostic / imaging agent | 185 mbq | Intravenous |